Osteogenic actions of metoprolol in an ovariectomized rat model of menopause
Conclusions: Our findings indicate that metoprolol prevents estrogen deficiency-induced bone loss by increasing the number and enhancing the biological functions of osteoblasts, implying its potential use as an alternative treatment for postmenopausal osteoporosis in hypertensive patients.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Calcium | Epidemiology | Genetics | Hypertension | Men | Menopause | OBGYN | Orthopaedics | Osteoporosis | Ovaries | Study | Toprol | Women